Scientists have developed a new system for producing radioisotopes for cancer therapy. The system uses a simple radionuclide generator to repeatedly separate thorium-226 from its longer-lived parent isotope, uranium-230. The uranium-230/thorium-226 pair has the unique advantage of emitting multiple alpha particles as they decay, delivering more destructive energy to cancer cells.